In this article by Pharmaceutical Manufacturer, Thierry Van Nieuwenhove, CEO of Quotient Sciences, discusses how the company is innovating to meet the growing demand for personalized medicine through AI, partnerships and meeting sustainability goals.
Thierry talks through what strategies Quotient Sciences is implementing to address supply chain challenges in a post-pandemic world and what roles do digital transformation and AI play in improving efficiency in your manufacturing processes.
Continue reading the full article on Pharmaceutical Manufacturer.